These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 30808975)

  • 21. Role of a novel race-related tumor suppressor microRNA located in frequently deleted chromosomal locus 8p21 in prostate cancer progression.
    Bhagirath D; Yang TL; Tabatabai ZL; Shahryari V; Majid S; Dahiya R; Tanaka Y; Saini S
    Carcinogenesis; 2019 Jul; 40(5):633-642. PubMed ID: 30874288
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel microRNA regulator of prostate cancer epithelial-mesenchymal transition.
    Bucay N; Bhagirath D; Sekhon K; Yang T; Fukuhara S; Majid S; Shahryari V; Tabatabai Z; Greene KL; Hashimoto Y; Shiina M; Yamamura S; Tanaka Y; Deng G; Dahiya R; Saini S
    Cell Death Differ; 2017 Jul; 24(7):1263-1274. PubMed ID: 28498363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Networks of intergenic long-range enhancers and snpRNAs drive castration-resistant phenotype of prostate cancer and contribute to pathogenesis of multiple common human disorders.
    Glinskii AB; Ma S; Ma J; Grant D; Lim CU; Guest I; Sell S; Buttyan R; Glinsky GV
    Cell Cycle; 2011 Oct; 10(20):3571-97. PubMed ID: 22067658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
    Kiener M; Chen L; Krebs M; Grosjean J; Klima I; Kalogirou C; Riedmiller H; Kneitz B; Thalmann GN; Snaar-Jagalska E; Spahn M; Kruithof-de Julio M; Zoni E
    BMC Cancer; 2019 Jun; 19(1):627. PubMed ID: 31238903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pirin: a potential novel therapeutic target for castration-resistant prostate cancer regulated by miR-455-5p.
    Arai T; Kojima S; Yamada Y; Sugawara S; Kato M; Yamazaki K; Naya Y; Ichikawa T; Seki N
    Mol Oncol; 2019 Feb; 13(2):322-337. PubMed ID: 30444038
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer.
    Gui B; Hsieh CL; Kantoff PW; Kibel AS; Jia L
    PLoS One; 2017; 12(9):e0184166. PubMed ID: 28886115
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MiR-644a Disrupts Oncogenic Transformation and Warburg Effect by Direct Modulation of Multiple Genes of Tumor-Promoting Pathways.
    Ebron JS; Shankar E; Singh J; Sikand K; Weyman CM; Gupta S; Lindner DJ; Liu X; Campbell MJ; Shukla GC
    Cancer Res; 2019 Apr; 79(8):1844-1856. PubMed ID: 30808676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. miR-483-5p promotes prostate cancer cell proliferation and invasion by targeting RBM5.
    Yang ZG; Ma XD; He ZH; Guo YX
    Int Braz J Urol; 2017; 43(6):1060-1067. PubMed ID: 28727371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen-induced miR-27A acted as a tumor suppressor by targeting MAP2K4 and mediated prostate cancer progression.
    Wan X; Huang W; Yang S; Zhang Y; Zhang P; Kong Z; Li T; Wu H; Jing F; Li Y
    Int J Biochem Cell Biol; 2016 Oct; 79():249-260. PubMed ID: 27594411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overexpression of long non-coding RNA NORAD promotes invasion and migration in malignant melanoma via regulating the MIR-205-EGLN2 pathway.
    Chen Y; Cao K; Li J; Wang A; Sun L; Tang J; Xiong W; Zhou X; Chen X; Zhou J; Liu Y
    Cancer Med; 2019 Apr; 8(4):1744-1754. PubMed ID: 30843652
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-302/367/LATS2/YAP pathway is essential for prostate tumor-propagating cells and promotes the development of castration resistance.
    Guo Y; Cui J; Ji Z; Cheng C; Zhang K; Zhang C; Chu M; Zhao Q; Yu Z; Zhang Y; Fang YX; Gao WQ; Zhu HH
    Oncogene; 2017 Nov; 36(45):6336-6347. PubMed ID: 28745315
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Androgen receptor-regulated miRNA-193a-3p targets AJUBA to promote prostate cancer cell migration.
    Jia L; Gui B; Zheng D; Decker KF; Tinay I; Tan M; Wang X; Kibel AS
    Prostate; 2017 Jun; 77(9):1000-1011. PubMed ID: 28422308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A Constitutive Intrinsic Inflammatory Signaling Circuit Composed of miR-196b, Meis2, PPP3CC, and p65 Drives Prostate Cancer Castration Resistance.
    Jeong JH; Park SJ; Dickinson SI; Luo JL
    Mol Cell; 2017 Jan; 65(1):154-167. PubMed ID: 28041912
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MicroRNA expression profile of primary prostate cancer stem cells as a source of biomarkers and therapeutic targets.
    Rane JK; Scaravilli M; Ylipää A; Pellacani D; Mann VM; Simms MS; Nykter M; Collins AT; Visakorpi T; Maitland NJ
    Eur Urol; 2015 Jan; 67(1):7-10. PubMed ID: 25234358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The identification of microRNAs in a genomically unstable region of human chromosome 8q24.
    Huppi K; Volfovsky N; Runfola T; Jones TL; Mackiewicz M; Martin SE; Mushinski JF; Stephens R; Caplen NJ
    Mol Cancer Res; 2008 Feb; 6(2):212-21. PubMed ID: 18314482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of novel miR-145-3p regulatory networks on survival in patients with castration-resistant prostate cancer.
    Goto Y; Kurozumi A; Arai T; Nohata N; Kojima S; Okato A; Kato M; Yamazaki K; Ishida Y; Naya Y; Ichikawa T; Seki N
    Br J Cancer; 2017 Jul; 117(3):409-420. PubMed ID: 28641312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. microRNA-340 Suppresses Tumorigenic Potential of Prostate Cancer Cells by Targeting High-Mobility Group Nucleosome-Binding Domain 5.
    Wei P; Qiao B; Li Q; Han X; Zhang H; Huo Q; Sun J
    DNA Cell Biol; 2016 Jan; 35(1):33-43. PubMed ID: 26394192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-200a suppresses prostate cancer progression through BRD4/AR signaling pathway.
    Guan H; You Z; Wang C; Fang F; Peng R; Mao L; Xu B; Chen M
    Cancer Med; 2019 Apr; 8(4):1474-1485. PubMed ID: 30784214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. RhoC is a major target of microRNA-93-5P in epithelial ovarian carcinoma tumorigenesis and progression.
    Chen X; Chen S; Xiu YL; Sun KX; Zong ZH; Zhao Y
    Mol Cancer; 2015 Feb; 14(1):31. PubMed ID: 25649143
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Silencing of miR-193a-5p increases the chemosensitivity of prostate cancer cells to docetaxel.
    Yang Z; Chen JS; Wen JK; Gao HT; Zheng B; Qu CB; Liu KL; Zhang ML; Gu JF; Li JD; Zhang YP; Li W; Wang XL; Zhang Y
    J Exp Clin Cancer Res; 2017 Dec; 36(1):178. PubMed ID: 29216925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.